Clete A. Kushida, M.D., Ph.D.

Publication Details

• Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS.

  Kushida CA, Becker PM, Ellenbogen AL, Canafax DM, Barrett RW. Neurology. 2009; 72 (5): 439-46

  To assess the efficacy and tolerability of the nondopaminergic agent XP13512/GSK1838262 in adults with moderate to severe primary restless legs syndrome (RLS).

  PubMedID: 19188575